AEON Biopharma's total assets for Q were $3.03M, a decrease of -82.79% from the previous quarter. AEON total liabilities were $201.41M for the fiscal quarter, a 44.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.